|
OxyphenbutazoneDrug - Oxyphenbutazone The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Oxyphenbutazone
Strength -
100MG
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
088399
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 17, 1984
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Watson Laboratories Inc
Oxyphenbutazone
Ocuclear 0.025% Solution/drops; Ophthalmic
Visine L.R. 0.025% Solution/drops; Ophthalmic Anadrol-50 50mg Tablet; Oral Numorphan 1.5mg/ml Injectable; Injection Numorphan 1mg/ml Injectable; Injection Numorphan 5mg Suppository; Rectal Oxyphenbutazone 100mg Tablet; Oral Oxycodone Hcl 30mg Tablet; Oral Roxicodone 15mg Tablet; Oral Roxicodone 30mg Tablet; Oral NewDrugInformation |